Skip to content
Home
Our Science
Pipeline & Assets
Team & Investors
Careers
News & Resources
Connect
News
& Resources
Featured Stories
Siren Biotechnology Announces FDA Clearance of First IND, Advancing Company to Clinical Stage
Read More
Siren Biotechnology to Showcase Clinical-Stage Momentum at Major 2026 Healthcare Conferences
Read More
Pepperdine Graziadio Business School
Siren Biotechnology named a 2025 Most Fundable Company
Read More
News
Patient Resources
Videos
Publications & Presentations
All
Media Coverage
Press Releases
Press Releases
|
Posted on 1.28.26
Siren Biotechnology Announces FDA Clearance of First IND, Advancing Company to Clinical Stage
Read More
Press Releases
|
Posted on 1.7.26
Siren Biotechnology to Showcase Clinical-Stage Momentum at Major 2026 Healthcare Conferences
Read More
Media Coverage
|
Posted on 9.26.25
Siren Biotechnology named a 2025 Most Fundable Company
Read More
Press Releases
|
Posted on 5.12.25
Siren Biotechnology to Present Universal AAV Immuno-Gene Therapy Data at the 2025 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
Read More
Media Coverage
|
Posted on 5.11.25
Siren, a gene therapy startup, tests unconventional alternative to venture funding
Read More
Media Coverage
|
Posted on 5.10.25
Signal Alert: Startup Seeks Community Funders for AAV Immuno-Gene Therapy
Read More
Media Coverage
|
Posted on 4.16.25
Siren community investment round featured in BiotechTV
Read More
Media Coverage
|
Posted on 4.16.25
Siren Biotechnology Opens Community Investment Round!
Read More
Media Coverage
|
Posted on 4.3.25
Siren CEO and Founder Dr. Nicole Paulk named in SFBT Women to Watch
Read More
Media Coverage
|
Posted on 4.3.25
Siren Biotechnology Presents at SXSW 2025
Read More
1
2
3
…
5
